$4.07+0.08 (+2.01%)
KORU Medical Systems, Inc.
KORU Medical Systems, Inc. in the Healthcare sector is trading at $4.07. The stock is currently 38% below its 52-week high of $6.61, remaining 10.2% below its 200-day moving average. Technical signals show neutral RSI of 39 and bullish MACD crossover, explaining why KRMD maintains its current current market pressure. The Whystock Score of 70/100 reflects a high-conviction bullish alignment.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to del...
We can readily understand why investors are attracted to unprofitable companies. For example, although...
Phreesia (PHR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
KRMD secures EU MDR certification for its Freedom60 Infusion Pump, opening broader EU access and boosting adoption of patient-friendly home infusion solutions.
Moby summary of KORU Medical Systems, Inc.'s Q4 2025 earnings call
KORU Medical Systems Inc (KRMD) reports a 22% revenue increase and new pharma collaborations, despite facing geopolitical and market challenges.